JP2022530049A5 - - Google Patents

Info

Publication number
JP2022530049A5
JP2022530049A5 JP2021562988A JP2021562988A JP2022530049A5 JP 2022530049 A5 JP2022530049 A5 JP 2022530049A5 JP 2021562988 A JP2021562988 A JP 2021562988A JP 2021562988 A JP2021562988 A JP 2021562988A JP 2022530049 A5 JP2022530049 A5 JP 2022530049A5
Authority
JP
Japan
Prior art keywords
oxadiazole
acetamide
piperidine
chloro
fluorophenoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021562988A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022530049A (ja
JP7590343B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/061150 external-priority patent/WO2020216766A1/en
Publication of JP2022530049A publication Critical patent/JP2022530049A/ja
Publication of JP2022530049A5 publication Critical patent/JP2022530049A5/ja
Priority to JP2024198168A priority Critical patent/JP7878648B2/ja
Application granted granted Critical
Publication of JP7590343B2 publication Critical patent/JP7590343B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021562988A 2019-04-23 2020-04-22 統合ストレス応答経路のモジュレーター Active JP7590343B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024198168A JP7878648B2 (ja) 2019-04-23 2024-11-13 統合ストレス応答経路のモジュレーター

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP19170504.5 2019-04-23
EP19170504 2019-04-23
EP19216875.5 2019-12-17
EP19216875 2019-12-17
PCT/EP2020/061150 WO2020216766A1 (en) 2019-04-23 2020-04-22 Modulators of the integrated stress response pathway

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024198168A Division JP7878648B2 (ja) 2019-04-23 2024-11-13 統合ストレス応答経路のモジュレーター

Publications (3)

Publication Number Publication Date
JP2022530049A JP2022530049A (ja) 2022-06-27
JP2022530049A5 true JP2022530049A5 (cg-RX-API-DMAC7.html) 2023-04-27
JP7590343B2 JP7590343B2 (ja) 2024-11-26

Family

ID=70289816

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021562988A Active JP7590343B2 (ja) 2019-04-23 2020-04-22 統合ストレス応答経路のモジュレーター
JP2024198168A Active JP7878648B2 (ja) 2019-04-23 2024-11-13 統合ストレス応答経路のモジュレーター

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024198168A Active JP7878648B2 (ja) 2019-04-23 2024-11-13 統合ストレス応答経路のモジュレーター

Country Status (15)

Country Link
US (2) US12258338B2 (cg-RX-API-DMAC7.html)
EP (1) EP3959198A1 (cg-RX-API-DMAC7.html)
JP (2) JP7590343B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220004105A (cg-RX-API-DMAC7.html)
CN (1) CN113993850B (cg-RX-API-DMAC7.html)
AU (2) AU2020261234B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021020402A2 (cg-RX-API-DMAC7.html)
CL (1) CL2021002772A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021014292A2 (cg-RX-API-DMAC7.html)
IL (1) IL287379B2 (cg-RX-API-DMAC7.html)
MX (2) MX2021012903A (cg-RX-API-DMAC7.html)
PE (1) PE20220961A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202111119PA (cg-RX-API-DMAC7.html)
WO (1) WO2020216766A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202108151B (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201920129A (zh) 2017-09-01 2019-06-01 美商戴納立製藥公司 化合物、組合物及方法
JP2021508336A (ja) 2017-12-13 2021-03-04 プラクシス バイオテック エルエルシー 統合的ストレス応答経路の阻害剤
US11166942B2 (en) 2018-06-05 2021-11-09 Praxis Biotech LLC Inhibitors of integrated stress response pathway
EP3924341A4 (en) 2019-02-13 2022-11-02 Denali Therapeutics Inc. Compounds, compositions and methods
CR20210426A (es) * 2019-02-13 2021-09-30 Denali Therapeutics Inc Compuestos, composiciones y métodos
MX2021012904A (es) * 2019-04-23 2022-01-18 Evotec Int Gmbh Moduladores de la via de respuesta al estres integrada.
JP2022536663A (ja) 2019-06-12 2022-08-18 プラクシス バイオテック エルエルシー 統合的ストレス応答経路のモジュレーター
WO2021165927A1 (en) * 2020-02-21 2021-08-26 Wockhardt Bio Ag 2-cyanopyrroldines, -piperidines or -dazepines as hyperglycemic agents
KR20220151635A (ko) 2020-03-11 2022-11-15 에보텍 인터내셔널 게엠베하 통합 스트레스 반응 경로의 조절제
MX2023004677A (es) * 2020-10-22 2023-05-24 Evotec Int Gmbh Moduladores de la via de respuesta integrada al estres.
ES2997335T3 (en) 2020-10-22 2025-02-17 Evotec Int Gmbh Modulators of the integrated stress response pathway
CA3195290A1 (en) 2020-10-22 2022-04-28 Holly Victoria Atton Modulators of the integrated stress response pathway
TW202241857A (zh) 2020-12-18 2022-11-01 美商戴納立製藥公司 化合物之固體形式
WO2022212902A1 (en) * 2021-04-02 2022-10-06 Altos Labs, Inc. Modulators of integrated stress response pathway
AU2023384649A1 (en) 2022-11-21 2025-05-22 Shenzhen Zhongge Biological Technology Co., Ltd. Compound, pharmaceutical composition containing same, synthesis method therefor and use thereof
CN116854623B (zh) * 2023-07-11 2025-08-05 齐鲁安替制药有限公司 一种阿维巴坦中间体的制备方法
CN121986087A (zh) 2023-10-13 2026-05-05 国立研究开发法人国立精神·神经医疗研究中心 神经保护剂
AU2024406222A1 (en) 2023-12-20 2026-06-04 Bristol-Myers Squibb Company Antibodies targeting il-18 receptor beta (il-18rβ) and related methods

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6639761B1 (en) 1999-12-02 2003-10-28 Seagate Technology Llc Micro-actuator damping and humidity protection
AU2001233044A1 (en) * 2000-01-28 2001-08-07 Akkadix Corporation Methods for killing nematodes and nematode eggs using bis-amino-1,2,4-thiadiazoles
US7915433B2 (en) 2004-04-16 2011-03-29 Wayne State University Tri-substituted 2-benzhydryl 5-benzlamino-tetrahydro-pyran-4-OL and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-OL analogues, and novel 3,6 disubstituted pyran derivatives
WO2014144952A2 (en) * 2013-03-15 2014-09-18 Peter Walter Modulators of the eif2alpha pathway
EA201692557A1 (ru) 2014-07-04 2017-05-31 Люпин Лимитед Хинолизиноновые производные в качестве ингибиторов pi3k
WO2017046739A1 (en) 2015-09-15 2017-03-23 Glaxosmithkline Intellectual Property (No.2) Limited Imidazolidinone derivatives as inhibitors of perk
TW201722957A (zh) * 2015-09-15 2017-07-01 葛蘭素史克智慧財產(第二)有限公司 化學化合物
TW201808888A (zh) 2016-05-05 2018-03-16 嘉來克生命科學有限責任公司 整合應激途徑之調節劑
TW201808914A (zh) * 2016-05-05 2018-03-16 嘉來克生命科學有限責任公司 整合應激途徑之調節劑
TW201808903A (zh) 2016-05-05 2018-03-16 嘉來克生命科學有限責任公司 整合應激途徑之調節劑
TWI920577B (zh) 2016-05-05 2026-04-01 美商嘉來克生命科學有限責任公司 整合應激途徑之調節劑
CA3026983A1 (en) * 2016-06-08 2017-12-14 Glaxosmithkline Intellectual Property Development Limited Chemical compounds
RU2018145734A (ru) * 2016-06-08 2020-07-14 Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед Химические соединения в качестве ингибиторов atf4 пути
CN110730777A (zh) 2017-06-07 2020-01-24 葛兰素史密斯克莱知识产权发展有限公司 作为atf4通路抑制剂的化学化合物
EP3649108A1 (en) 2017-07-03 2020-05-13 GlaxoSmithKline Intellectual Property Development Limited 2-(4-chlorophenoxy)-n-((1 -(2-(4-chlorophenoxy)ethynazetidin-3-yl)methyl)acetamide derivatives and related compounds as atf4 inhibitors for treating cancer and other diseases
WO2019008506A1 (en) 2017-07-03 2019-01-10 Glaxosmithkline Intellectual Property Development Limited N- (3- (2- (4-CHLOROPHENOXY) ACETAMIDO) BICYCLO [1.1.1] PENTAN-1-YL) -2-CYCLOBUTANE-1-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ATF4 INHIBITORS FOR THE TREATMENT OF CANCER AND OTHER DISEASES
DE102017213834A1 (de) * 2017-08-08 2019-02-14 Robert Bosch Gmbh Sende-/Empfangseinrichtung für ein Bussystem und Verfahren zur Reduzierung einer Schwingneigung beim Übergang zwischen unterschiedlichen Bitzuständen
IL301709B2 (en) 2017-08-09 2025-07-01 Denali Therapeutics Inc Compounds, compositions and methods
TW201920129A (zh) 2017-09-01 2019-06-01 美商戴納立製藥公司 化合物、組合物及方法
BR112020008825A2 (pt) 2017-11-02 2020-10-20 Calico Life Sciences Llc moduladores da via de estresse integrada
MX2020004537A (es) 2017-11-02 2020-10-05 Calico Life Sciences Llc Moduladores de la vía integrada del estrés.
JP2021501785A (ja) 2017-11-02 2021-01-21 カリコ ライフ サイエンシーズ エルエルシー 統合的ストレス経路の調節剤
EP3704125B1 (en) 2017-11-02 2026-03-11 Calico Life Sciences LLC Modulators of the integrated stress pathway
MX2020004538A (es) 2017-11-02 2020-09-18 Calico Life Sciences Llc Moduladores de la vía de estrés integrada.
UY37958A (es) 2017-11-02 2019-05-31 Abbvie Inc Moduladores de la vía de estrés integrada
UY37956A (es) 2017-11-02 2019-05-31 Abbvie Inc Moduladores de la vía de estrés integrada
SG11202004009TA (en) 2017-11-02 2020-05-28 Calico Life Sciences Llc Modulators of the integrated stress pathway
UY37957A (es) 2017-11-02 2019-05-31 Abbvie Inc Moduladores de la vía de estrés integrada
JP2021508336A (ja) 2017-12-13 2021-03-04 プラクシス バイオテック エルエルシー 統合的ストレス応答経路の阻害剤
WO2019183589A1 (en) 2018-03-23 2019-09-26 Denali Therapeutics Inc. Modulators of eukaryotic initiation factor 2
WO2019193541A1 (en) 2018-04-06 2019-10-10 Glaxosmithkline Intellectual Property Development Limited Bicyclic aromatic ring derivatives of formula (i) as atf4 inhibitors
WO2019193540A1 (en) 2018-04-06 2019-10-10 Glaxosmithkline Intellectual Property Development Limited Heteroaryl derivatives of formula (i) as atf4 inhibitors

Similar Documents

Publication Publication Date Title
JP2023511616A5 (cg-RX-API-DMAC7.html)
JP2022530051A5 (cg-RX-API-DMAC7.html)
JP2023514872A5 (cg-RX-API-DMAC7.html)
JP2023517944A5 (cg-RX-API-DMAC7.html)
JP2019077725A5 (cg-RX-API-DMAC7.html)
JP2014511869A5 (cg-RX-API-DMAC7.html)
JP2014525444A5 (cg-RX-API-DMAC7.html)
HRP20191140T1 (hr) Spojevi i pripravci kao inhibitori c-kit kinaze
JP2013516415A5 (cg-RX-API-DMAC7.html)
JP2012525349A5 (cg-RX-API-DMAC7.html)
JP2016510035A5 (cg-RX-API-DMAC7.html)
ME02053B (me) Oksazol supstituisani indazoli kao inhibitori pi3-kinaze
EA035256B1 (ru) Ингибиторы аутотаксинов, содержащие гетероарил-бензил-амидное ядро
JP2021535134A5 (cg-RX-API-DMAC7.html)
JP2016518344A5 (cg-RX-API-DMAC7.html)
WO2004089367A1 (en) Pharmaceutical use of substituted 1,2,4-triazoles
RU2011151277A (ru) Мостиковые производные спиро[2.4]гептана в качестве агонистов рецептора alx и/или fprl2
RU2009126624A (ru) Производные 2-(пиперидин-4-ил)-4-фенокси-или фенилаинопиримидина в качестве ненуклеозидных ингибитров обратной транскриптазы
JP2013507449A5 (cg-RX-API-DMAC7.html)
CA2610888A1 (en) Inhibitors of akt activity
JP2008517976A5 (cg-RX-API-DMAC7.html)
RU2013138569A (ru) Антагонисты рецептора минералокортикоидов
HRP20161011T1 (hr) Aril dihidropiridinoni i piperidinoni kao inhibitori mgat2
EP3959198A1 (en) Modulators of the integrated stress response pathway
JP2021515004A5 (cg-RX-API-DMAC7.html)